Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee
Drug Tariff Watch: February 2019 changes
Please note the upcoming changes to the way you access the Drug Tariff. The Preface lists additions, deletions and alterations to the Drug Tariff. Below is a quick summary of the changes due to take place from 1st February 2019. Part VIIIA additions Bupivacaine 25mg/10ml (0.25%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection...
Reminder: End of January payment
Community pharmacy contractors are reminded that, due to changes that came into effect with the November 2018 Drug Tariff, they should be aware that their January payment from NHS Prescription Services is likely to be lower than in previous months. The time-lag in pricing prescriptions means that pharmacy payments aren’t affected straight away. As such,...
Wish list of pharmacy IT system suggested features published
Following discussions at its recent meetings and feedback from pharmacy teams, the Community Pharmacy IT Group (CP ITG) has published a list of features that pharmacy teams would like their patient medication record (PMR) IT systems to include: PMR wish list and briefing on use and development of pharmacy systems (published January 2019) Requested features include: Speedy to use, touch-screen systems that enable quicker recording or access to clinical observations, actions and progress; more compatibility with...
Quality Payments: Have you accessed the SCR portal to validate whether your pharmacy meets the WES criterion?
Community pharmacy contractors who have not been validated as meeting the Warranted Environment Specification (WES) gateway criterion of the Quality Payments Scheme by the NHS Business Services Authority (NHS BSA) are reminded of the need to access the Summary Care Record (SCR) portal by Thursday 24th January 2019 if they want their pharmacy to be assessed...
January edition of CPN magazine now available
The January 2019 edition of PSNC’s Community Pharmacy News (CPN) is now available. This month’s CPN features: NHS ten-year plan published; IG support materials; Quality Payments declaration; and Price concession flow chart. View our CPN magazine online via the flipbook reader below or download the PDF copy. Please note, the colour PDF can be printed...
#checkbeforeyoutick – how can you help?
The NHS Business Services Authority’s ‘Check Before You Tick’ campaign aims to help patients understand their eligibility for free NHS prescriptions, and to highlight the possible consequences of making an incorrect claim. We spoke to Tori Hutchinson who worked on the campaign to find out more. Hi I’m Tori and I’m a Lead Digital Delivery Manager at...
January 2019 Price Concessions/NCSO – 1st update
Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions: Drug Pack size Price Concession Allopurinol 100mg tablets 28 £1.70 Allopurinol 300mg tablets 28 £3.68 Co-careldopa 25mg/100mg tablets 100 £10.69 Diamorphine 10mg powder for solution for injection ampoules 5 £16.56 Diamorphine 30mg powder for solution for injection ampoules...
Ask PSNC: Quality Payments FAQs
The team at PSNC has received a number of queries on the Quality Payments Scheme. Below are some of the questions asked in recent weeks. Q. How do I upload the Community Pharmacy Patient Questionnaire results to the pharmacy’s NHS website page? A user guide on the process to follow to upload the CPPQ onto an NHS website profile is available on the NHS...
Serious Shortage Protocols: Draft legislation laid
Draft legislation on Serious Shortage Protocols (SSPs) has been laid before Parliament and should come into force in early February 2019. This follows consultation between the Department of Health and Social Care (DHSC) and stakeholders, including PSNC and other pharmacy representative bodies. SPPs are protocols for pharmacies that will be put in place in the...
No-deal Brexit preparations: NHS England update
Dr Keith Ridge, NHS England’s Chief Pharmaceutical Officer, has today (January 18th 2019) written to community pharmacies to update them on the continuity of supply of medicines as part of the Government’s contingency preparations for a no-deal exit from the European Union (EU). Read the letter from Dr Keith Ridge here: https://www.england.nhs.uk/publication/medicine-supply-update-letter-from-dr-keith-ridge-cbe/) The letter reiterates...
PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS
Abcam and Loulou Foundation form CDKL5 deficiency disorder partnership
Abcam has announced a research collaboration with the Loulou Foundation to discover new tools to advance research for the development of therapeutics for CDKL5 Deficiency Disorder.
Superdrug to offer stricter mental health checks for Botox users
NHS England's medical director has welcomed the introduction of stronger mental health safeguards for Superdrug's new high street botox plan.
Orkambi's use expanded for younger children
The European Commission has expanded the use of Orkambi to include children with cystic fibrosis aged two years to five years.
MHRA grants approval for RXC004 trial restart
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given formal approval for Redx Pharma to re-commence a Phase I/IIa trial of experimental cancer therapy RXC004.
Genetic study reveals possible new osteoarthritis treatment
Scientists have uncovered 52 new genetic changes linked to osteoarthritis, doubling the number of genetic regions found to be associated with the disabling condition, potentially paving the way for the development of disease-modifying therapies.
Shield appoints James Karis as new chairman
Shield Therapeutics has appointed James Karis as non-executive chairman of the company, with immediate effect.
It’s not too late to start your application and beat the January 31st deadline
With entries already surpassing the overall for last year, this year’s 20th anniversary edition of the competition is shaping up to be our largest one yet – so join your fellow peers and enter now!
Jon Neal to head up Takeda & Shire partnership
Following the completion of the Shire acquisition, Takeda UK & Ireland has announced Jon Neal as general manager of the combined company.
L.E.K. Consulting promotes Sej Brar to partner
Sej Brar has been promoted to a partner in the London Pharma & Life Sciences practice of L.E.K. Consulting, the global strategy consultancy.
MAGI Boston conference 2019 - benefits available for clinical researcher of the year finalists
MAGI and PharmaTimes have teamed up to offer Clinical Researcher of the Year - The Americas finalists discounts at the MAGI Boston conference in May.
Canopy Growth to open UK medicinal cannabis branch
US based Canopy Growth has declared its intent to enter the UK market, by unveiling new pharmaceutical company Spectrum Biomedical UK - a joint venture between Canopy Growth and Beckley Canopy.
NAO report highlights NHS financial deficit
NHS trusts and foundation trusts have booked a combined deficit of £991 million for 2017/18, according to the National Audit Office's latest report on NHS financial sustainability.
Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.
Find out more: https://www.cphi.com/europe/